ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-β peptide (1-40) at the blood-brain barrier

被引:42
作者
Akanuma, Shin-Ichi [1 ]
Ohtsuki, Sumio [1 ]
Doi, Youko [1 ]
Tachikawa, Masanori [1 ]
Ito, Shingo [1 ]
Hori, Satoko [1 ]
Asashima, Tomoko [1 ]
Hashimoto, Tadafumi [2 ]
Yamada, Kaoru [2 ]
Ueda, Kazumitsu [3 ]
Iwatsubo, Takeshi [2 ]
Terasaki, Tetsuya [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Aoba Ku, Sendai, Miyagi 9808578, Japan
[2] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[3] Kyoto Univ, Lab Cellular Biochem, Div Appl Life Sci, Grad Sch Agr, Kyoto 6068502, Japan
基金
日本学术振兴会;
关键词
Alzheimer's disease; ATP-binding cassette transporter; mouse blood-brain barrier; amyloid-beta peptide (1-40); ABCA1; mouse brain efflux index study; ABCA1 knockout mouse; LXR;
D O I
10.1016/j.neuint.2007.12.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP-binding cassette transporter A1 (ABCA1) mediates apolipoprotein-dependent cholesterol release from cellular membranes. Recent studies using ABCA1 knockout mice have demonstrated that ABCAI affects amyloid-beta peptide (A beta) levels in the brain and the production of senile plaque. Cerebral A beta(1-40) was eliminated from the brain to the circulating blood via the blood-brain barrier (BBB), which expresses ABCA1. Therefore, in the present study, we examined whether ABCAI affects the brain-to-blood efflux transport of human A beta(1-40)(hA beta(1-40)) at the BBB. The apparent uptake of [I-125]hA beta(1-40) into ABCA1-expressing HEK293 cells was not significantly different from that into parental HEK293 cells. In addition, the apparent uptake was not significantly affected even in the presence of apolipoprotein A-I as a cholesterol release acceptor. Moreover, [I-125]hA beta(1-40) elimination from mouse brain across the BBB was not significantly different between ABCA1-deficient and wild-type mice 60 min after its administration into the cerebrum. These results suggest that ABCAI does not directly transport hA beta(1-40) and a deficiency of ABCAI does not attenuate the brain-to-blood efflux transport of hA beta(1-40) across the BBB. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:956 / 961
页数:6
相关论文
共 33 条
[1]  
AKANUMA S, 2007, NEUROCHEM INT 0826
[2]   Raft and cytoskeleton associations of an ABC transporter:: P-glycoprotein [J].
Bacso, Z ;
Nagy, H ;
Goda, K ;
Bene, L ;
Fenyvesi, F ;
Matkó, J ;
Szabó, G .
CYTOMETRY PART A, 2004, 61A (02) :105-116
[3]   Blood-brain barrier transport of a novel μ1-specific opioid peptide, H-Tyr-D-Arg-Phe-β-Ala-OH (TAPA) [J].
Deguchi, Y ;
Miyakawa, Y ;
Sakurada, S ;
Naito, Y ;
Morimoto, K ;
Ohtsuki, S ;
Hosoya, K ;
Terasaki, T .
JOURNAL OF NEUROCHEMISTRY, 2003, 84 (05) :1154-1161
[4]   Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan [J].
Deguchi, Y ;
Okutsu, H ;
Okura, T ;
Yamada, S ;
Kimura, R ;
Yuge, T ;
Furukawa, A ;
Morimoto, K ;
Tachikawa, M ;
Ohtsuki, S ;
Hosoya, K ;
Terasaki, T .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (02) :381-389
[5]   Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels [J].
Fukumoto, H ;
Deng, A ;
Irizarry, MC ;
Fitzgerald, ML ;
Rebeck, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48508-48513
[6]   ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. [J].
Hamon, Y ;
Broccardo, C ;
Chambenoit, O ;
Luciani, MF ;
Toti, F ;
Chaslin, S ;
Freyssinet, JM ;
Devaux, PF ;
McNeish, J ;
Marguet, D ;
Chimini, G .
NATURE CELL BIOLOGY, 2000, 2 (07) :399-406
[7]   In vivo delivery of small interfering RNA targeting brain capillary endothelial cells [J].
Hino, T ;
Yokota, T ;
Ito, S ;
Nishina, K ;
Kang, YS ;
Mori, S ;
Hori, S ;
Kanda, T ;
Terasaki, T ;
Mizusawa, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (01) :263-267
[8]   The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease [J].
Hirsch-Reinshagen, V ;
Maia, LF ;
Burgess, BL ;
Blain, JF ;
Naus, KE ;
McIsaac, SA ;
Parkinson, PF ;
Chan, JY ;
Tansley, GH ;
Hayden, MR ;
Poirier, J ;
Van Nostrand, W ;
Wellington, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :43243-43256
[9]   Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain [J].
Hirsch-Reinshagen, V ;
Zhou, S ;
Burgess, BL ;
Bernier, L ;
McIsaac, SA ;
Chan, JY ;
Tansley, GH ;
Cohn, JS ;
Hayden, MR ;
Wellington, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (39) :41197-41207
[10]  
Hosoya K, 2000, AAPS PHARMSCI, V2